FDAClass IIAugust 9, 2023

rocuronium recall: Sterility Concern

rocuronium, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA…

Why was rocuronium recalled?

Lack of assurance of sterility: Lack of validation data for sanitization cycles

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: 17-270519, Exp. 7/16/2023; 17-270605, Exp. 7/17/2023; 17-270684, Exp. 7/18/2023; 17-270898, Exp. 7/20/2023; 17-271074, Exp. 7/24/2023; 17-271324, Exp. 7/27/2023; 17-271603, Exp. 8/1/2023; 17-271670, Exp. 8/2/2023; 17-272529, Exp. 8/17/2023; 17-272883, Exp. 8/23/2023; 17-273235, 17-273245, 17-273262, 17-273263, 17-273264, Exp. 8/30/2023; 17-273418, Exp. 9/3/2023; 17-273768, 17-273788, Exp. 9/7/2023; 17-274022, Exp. 9/12/2023.

Product
rocuronium, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA…
Recalling firm
Central Admixture Pharmacy Services Inc
Quantity
10,065 syringes
Distribution
Nationwide in the USA
Recall date
August 9, 2023
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls